Literature DB >> 16042932

Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement.

Harold J Brody1.   

Abstract

BACKGROUND: In the past, reactions or misplacement of soft tissue fillers has been fraught with anxiety because time has been the main thrust for improvement in spite of ancillary treatments. Hyaluronidase is an enzyme that dissolves hyaluronic acid in the skin and also assists in the management of granulomatous foreign-body reactions to hyaluronic acid. These reactions may be caused by allergy to the material or immunologic response to the protein contaminants in the hyaluronic acid preparations. Dissolution of material in erroneous placement of material and in allergic reactions can be a time saver and a deterrent to patient dissatisfaction.
OBJECTIVE: To evaluate the use of hyaluronidase in the treatment of both allergic reactions and the erroneous misplacement of hyaluronic acid in the skin.
METHODS: A case of persistent granulomatous reaction to injectable hyaluronic acid and a case of hyaluronic acid erroneous misplacement with their successful subsequent treatments using intracutaneous hyaluronidase are reported, along with illustrative examples of hyaluronidase use.
RESULTS: The use of hyaluronidase reduced the patient discomfort within 24 to 48 hours, deterring any patient anxiety or patient dissatisfaction.
CONCLUSIONS: Hyaluronidase has a place in the treatment of allergic reactions to hyaluronic acid [corrected] and in the erroneous misplacement of the material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042932     DOI: 10.1097/00042728-200508000-00001

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  27 in total

1.  [History and use of fillers for treating wrinkles].

Authors:  L G Wiest
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

2.  Management of Tyndall Effect.

Authors:  Martyn King
Journal:  J Clin Aesthet Dermatol       Date:  2016-11-01

3.  Management of Delayed Onset Nodules.

Authors:  Martyn King; Stephen Bassett; Emma Davies; Sharon King
Journal:  J Clin Aesthet Dermatol       Date:  2016-11-01

4.  [Massive granuloma formation after long-term use of dermal fillers].

Authors:  E M Roider; G Gauglitz; M J Flaig; T Ruzicka; J Schauber
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

5.  A case of complication after matridex(r) injection.

Authors:  Sun Young Huh; Soyun Cho; Kyu Han Kim; Jee Soo An; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Kee Chan Moon
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

6.  Fillers: contraindications, side effects and precautions.

Authors:  Philippe Lafaille; Anthony Benedetto
Journal:  J Cutan Aesthet Surg       Date:  2010-01

7.  Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion.

Authors:  Gillian Murray; Cormac Convery; Lee Walker; Emma Davies
Journal:  J Clin Aesthet Dermatol       Date:  2021-05-01

Review 8.  Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler.

Authors:  Du Geon Moon; Tae Il Kwak; Je Jong Kim
Journal:  World J Mens Health       Date:  2015-08-19       Impact factor: 5.400

9.  Facial granulomas secondary to injection of semi-permanent cosmetic dermal filler containing acrylic hydrogel particles.

Authors:  Mukta Sachdev; Yn Anantheswar; Bc Ashok; Sunaina Hameed; Sanjay A Pai
Journal:  J Cutan Aesthet Surg       Date:  2010-09

10.  Dermal Fillers for the Treatment of Tear Trough Deformity: A Review of Anatomy, Treatment Techniques, and their Outcomes.

Authors:  Jaishree Sharad
Journal:  J Cutan Aesthet Surg       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.